Compare 3M Company (MMM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
3M Company vs Recursion Pharmaceuticals Inc — how do they compare? 3M Company trades at $170.75 (market cap $82.99B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: 3M Company is far larger — about 54.2× Recursion Pharmaceuticals Inc's market cap, and 3M Company pays a 1.96% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| MMM | RXRX | |
|---|---|---|
Market Cap | $82.99B | $1.53B |
Sector | Industrials | Health |
52-Week High | $174.61 | $6.79 |
52-Week Low | $141.10 | $2.84 |
Enterprise Value | $91.39B | $946.50M |
Dividend Yield | 1.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
